Joel Isaacson & Co’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $354K | Buy |
3,425
+634
| +23% | +$56.6K | 0.01% | 356 |
|
|
2026
Q1 | $200K | Sell |
2,791
-327
| -10% | -$25.2K | 0.01% | 432 |
|
|
2025
Q4 | $247K | Hold |
3,118
| – | – | 0.01% | 399 |
|
|
2025
Q3 | $235K | Buy |
+3,118
| New | +$214K | 0.01% | 406 |
|
|
2024
Q4 | – | Sell |
-5,473
| Closed | -$344K | – | 381 |
|
|
2024
Q3 | $344K | Buy |
5,473
+2,000
| +58% | +$117K | 0.02% | 270 |
|
|
2024
Q2 | $205K | Sell |
3,473
-795
| -19% | -$49.7K | 0.01% | 330 |
|
|
2024
Q1 | $340K | Sell |
4,268
-75
| -2% | -$5.73K | 0.02% | 261 |
|
|
2023
Q4 | $343K | Buy |
4,343
+179
| +4% | +$12.7K | 0.02% | 237 |
|
|
2023
Q3 | $291K | Sell |
4,164
-25
| -0.6% | -$1.77K | 0.02% | 246 |
|
|
2023
Q2 | $290K | Hold |
4,189
| – | – | 0.02% | 263 |
|
|
2023
Q1 | $311K | Sell |
4,189
-519
| -11% | -$43.5K | 0.02% | 252 |
|
|
2022
Q4 | $439K | Buy |
4,708
+124
| +3% | +$12K | 0.03% | 200 |
|
|
2022
Q3 | $437K | Buy |
4,584
+1,054
| +30% | +$104K | 0.04% | 177 |
|
|
2022
Q2 | $327K | Buy |
3,530
+41
| +1% | +$4K | 0.03% | 217 |
|
|
2022
Q1 | $361K | Hold |
3,489
| – | – | 0.03% | 225 |
|
|
2021
Q4 | $360K | Buy |
3,489
+170
| +5% | +$15.7K | 0.02% | 234 |
|
|
2021
Q3 | $282K | Buy |
3,319
+27
| +0.8% | +$2.26K | 0.02% | 255 |
|
|
2021
Q2 | $275K | Buy |
3,292
+100
| +3% | +$8.19K | 0.02% | 245 |
|
|
2021
Q1 | $240K | Buy |
3,192
+200
| +7% | +$14.6K | 0.02% | 237 |
|
|
2020
Q4 | $204K | Sell |
2,992
-15,750
| -84% | -$1.02M | 0.02% | 228 |
|
|
2020
Q3 | $1.09M | Hold |
18,742
| – | – | 0.14% | 76 |
|
|
2020
Q2 | $1.22M | Buy |
18,742
+28
| +0.1% | +$1.76K | 0.17% | 64 |
|
|
2020
Q1 | $1.11M | Buy |
18,714
+875
| +5% | +$58.4K | 0.19% | 59 |
|
|
2019
Q4 | $1.32M | Hold |
17,839
| – | – | 0.17% | 57 |
|
|
2019
Q3 | $1.13M | Sell |
17,839
-5,193
| -23% | -$308K | 0.16% | 64 |
|
|
2019
Q2 | $1.25M | Sell |
23,032
-402
| -2% | -$21.6K | 0.18% | 59 |
|
|
2019
Q1 | $1.26M | Buy |
23,434
+668
| +3% | +$41.2K | 0.18% | 65 |
|
|
2018
Q4 | $1.5M | Sell |
22,766
-5,549
| -20% | -$414K | 0.24% | 51 |
|
|
2018
Q3 | $2.23M | Sell |
28,315
-3,996
| -12% | -$286K | 0.35% | 31 |
|
|
2018
Q2 | $2.08M | Sell |
32,311
-5,980
| -16% | -$394K | 0.35% | 31 |
|
|
2018
Q1 | $2.38M | Sell |
38,291
-897
| -2% | -$64.4K | 0.42% | 29 |
|
|
2017
Q4 | $2.84M | Sell |
39,188
-5,041
| -11% | -$366K | 0.49% | 25 |
|
|
2017
Q3 | $3.6M | Sell |
44,229
-196
| -0.4% | -$15.5K | 0.66% | 17 |
|
|
2017
Q2 | $3.57M | Buy |
44,425
+3
| +0% | +$237 | 0.68% | 17 |
|
|
2017
Q1 | $3.49M | Buy |
44,422
+3
| +0% | +$240 | 0.68% | 17 |
|
|
2016
Q4 | $3.5M | Sell |
44,419
-243
| -0.5% | -$19.7K | 0.71% | 18 |
|
|
2016
Q3 | $3.97M | Sell |
44,662
-144
| -0.3% | -$13.6K | 0.82% | 17 |
|
|
2016
Q2 | $4.29M | Buy |
44,806
+3
| +0% | +$299 | 0.91% | 17 |
|
|
2016
Q1 | $4.65M | Buy |
44,803
+295
| +0.7% | +$28.7K | 1.03% | 13 |
|
|
2015
Q4 | $4.35M | Buy |
44,508
+2
| +0% | +$196 | 1.07% | 12 |
|
|
2015
Q3 | $4.29M | Buy |
44,506
+71
| +0.2% | +$7.46K | 1.15% | 10 |
|
|
2015
Q2 | $4.66M | Sell |
44,435
-17,200
| -28% | -$1.76M | 1.19% | 10 |
|
|
2015
Q1 | $6.36M | Buy |
61,635
+77
| +0.1% | +$7.79K | 1.6% | 8 |
|
|
2014
Q4 | $5.93M | Buy |
61,558
+1,954
| +3% | +$172K | 1.59% | 8 |
|
|
2014
Q3 | $4.74M | Buy |
59,604
+149
| +0.3% | +$11.7K | 1.45% | 9 |
|
|
2014
Q2 | $4.48M | Buy |
59,455
+1,386
| +2% | +$105K | 1.4% | 9 |
|
|
2014
Q1 | $4.35M | Buy |
58,069
+2
| +0% | +$141 | 1.46% | 9 |
|
|
2013
Q4 | $4.16M | Buy |
58,067
+1,528
| +3% | +$98.2K | 1.51% | 10 |
|
|
2013
Q3 | $3.21M | Buy |
56,539
+201
| +0.4% | +$12K | 1.31% | 11 |
|
|
2013
Q2 | $3.22M | Buy |
+56,338
| New | +$3.26M | 1.52% | 9 |
|
Other funds holding CVS
Joel Isaacson & Co's CVS Position: Q2 2026 in Review
Joel Isaacson & Co increased its CVS Health (CVS) stake by 23% in Q2 2026, buying an estimated $56.6K and bringing the position to 3,425 shares worth $354K. The position accounts for 0.01% of the portfolio, ranked #356.
Joel Isaacson & Co first reported a position in CVS in Q2 2013 and has held it in 50 quarters since. The position peaked at $6.36M in Q1 2015. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Joel Isaacson & Co held 3,425 shares of CVS Health worth $354K as of Q2 2026.
- Joel Isaacson & Co bought 634 CVS Health shares in Q2 2026, an estimated $56.6K.
- CVS Health made up 0.01% of Joel Isaacson & Co's portfolio in Q2 2026, its #356 holding.
- Joel Isaacson & Co first reported a position in CVS Health in Q2 2013 and has held it in 50 quarters since.
- Joel Isaacson & Co's CVS Health position peaked at $6.36M in Q1 2015.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Joel Isaacson & Co's 13F filing for Q2 2026, filed 4 Aug 2026.